Loading...
Development of a personalized therapeutic strategy for ERBB-gene-mutated cancers
BACKGROUND: The application of genomic technologies to patient tumor samples identified groups of signaling pathways which acquire activating mutations. Some cancers are dependent on these mutations and the aberrant proteins resulting from these mutations can be targeted by novel drugs which can era...
Na minha lista:
| Udgivet i: | Ther Adv Med Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5784557/ https://ncbi.nlm.nih.gov/pubmed/29383036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834017746040 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|